As Abbvie Com (ABBV) Market Value Declined, Sawgrass Asset Management Upped Position; As Gap Del (GPS) Share Value Declined, Gyroscope Capital Management Group Has Upped by $704,673 Its Stake

The Gap, Inc. (NYSE:GPS) Logo

Sawgrass Asset Management Llc increased its stake in Abbvie Inc. Com (ABBV) by 1781.18% based on its latest 2018Q3 regulatory filing with the SEC. Sawgrass Asset Management Llc bought 360,671 shares as the company’s stock declined 6.62% with the market. The institutional investor held 380,920 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $36.03 million, up from 20,249 at the end of the previous reported quarter. Sawgrass Asset Management Llc who had been investing in Abbvie Inc. Com for a number of months, seems to be bullish on the $136.64 billion market cap company. The stock increased 0.52% or $0.47 during the last trading session, reaching $90.84. About 3.28 million shares traded. AbbVie Inc. (NYSE:ABBV) has declined 7.04% since January 8, 2018 and is downtrending. It has underperformed by 7.04% the S&P500. Some Historical ABBV News: 13/04/2018 – AbbVie’s Humira Retail Sales Rose 0.4% in Latest Week: Symphony; 17/05/2018 – Eisai Announces Data at ASCO 2018 Annual Meeting Showcasing LENVIMA® (lenvatinib) and KEYTRUDA® (pembrolizumab) Combination Therapy Under Strategic Oncology Collaboration with Merck; 09/04/2018 – KEYTRUDA® (PEMBROLIZUMAB) MONOTHERAPY MET PRIMARY ENDPOINT IN PHASE 3 KEYNOTE-042 STUDY, SIGNIFICANTLY IMPROVING OS AS FIRST-LINE THERAPY IN LOCALLY ADVANCED OR METASTATIC NSCLC PATIENTS EXPRESSING P…; 06/03/2018 – AbbVie Gets Positive Recommendation From Pan-Canadian Oncology Drug Review for VENCLEXTA; 16/04/2018 – MEDIAN OVERALL SURVIVAL 11.3 MONTHS FOR CHEMOTHERAPY, NOT YET KNOWN FOR KEYTRUDA COMBINATION – DATA; 21/05/2018 – LANNETT COMPANY INC – FDA APPROVAL FOR DRONABINOL CAPSULES,THERAPEUTIC EQUIVALENT TO REFERENCE LISTED DRUG, MARINOL CAPSULES OF ABBVIE; 08/05/2018 – ONCOSEC EXPANDS RELATIONSHIP WITH MERCK, ANNOUNCES CLINICAL COLLABORATION TO EVALUATE COMBINATION OF IMMUNOPULSE® IL-12 AND KEYTRUDA® (PEMBROLIZUMAB) FOR TRIPLE NEGATIVE BREAST CANCER; 17/04/2018 – Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2018; 31/05/2018 – AbbVie to Present New Data from Several Investigational Studies of Venetoclax as Monotherapy or in Combination for the Manageme; 16/04/2018 – BIOTHERA PHARMACEUTICALS PRESENTS TRANSLATIONAL DATA FROM ONGOING CLINICAL TRIALS SHOWING IMPRIME PGG IN COMBINATION WITH MERCK’S KEYTRUDA® (PEMBROLIZUMAB) DRIVES INNATE AND ADAPTIVE IMMUNE

Gyroscope Capital Management Group Llc increased its stake in Gap Inc Del (GPS) by 12.16% based on its latest 2018Q3 regulatory filing with the SEC. Gyroscope Capital Management Group Llc bought 26,099 shares as the company’s stock declined 6.71% with the market. The institutional investor held 240,719 shares of the consumer services company at the end of 2018Q3, valued at $6.64M, up from 214,620 at the end of the previous reported quarter. Gyroscope Capital Management Group Llc who had been investing in Gap Inc Del for a number of months, seems to be bullish on the $9.64 billion market cap company. The stock decreased 4.05% or $1.07 during the last trading session, reaching $25.26. About 5.47 million shares traded or 3.79% up from the average. The Gap, Inc. (NYSE:GPS) has declined 19.95% since January 8, 2018 and is downtrending. It has underperformed by 19.95% the S&P500. Some Historical GPS News: 13/03/2018 – Alnylam Unveils Resources to `Bridge the Gap’ in Knowledge of Hereditary ATTR (hATTR) Amyloidosis Among Families at Risk; 05/03/2018 GAP INC GPS.N : INSTINET RAISES TARGET PRICE TO $33 FROM $31; 24/05/2018 – GAP AFFIRMS 2018 YEAR EPS; 22/03/2018 – Mad-Scientist Brewers Bridge the Gap Between Beer and Whiskey; 14/05/2018 – ROSS: THE GAP REMAINS WIDE BETWEEN U.S. AND CHINA ON TRADE; 06/03/2018 – PointClickCare and Redox to Bridge the Gap Between Acute and Post-Acute Markets with Strategic Partnership; 13/03/2018 – Alnylam Unveils Resources to ‘Bridge the Gap’ in Knowledge of Hereditary ATTR (hATTR) Amyloidosis Among Families at Risk; 08/03/2018 – Old Navy “Flower Empowers” NYC’s Historical Female Statues In Celebration Of International Women’s Day; 08/05/2018 – Email from Highly Reputable Senders is 23 Percent More Likely to Reach its lntended Audience—and the Gap is Growing; 22/03/2018 – GradeMaster Partners with SmartEdTech to Help Teachers Bridge the Gap between Assessment Data and Instruction

Sawgrass Asset Management Llc, which manages about $3.30B and $2.35 billion US Long portfolio, decreased its stake in Alphabet Inc Cl A by 23,638 shares to 63,318 shares, valued at $76.43M in 2018Q3, according to the filing. It also reduced its holding in Firstcash Inc Com by 11,175 shares in the quarter, leaving it with 8,917 shares, and cut its stake in Boise Cascade Corp Com (NYSE:BCC).

Investors sentiment decreased to 0.82 in Q3 2018. Its down 0.12, from 0.94 in 2018Q2. It dived, as 60 investors sold ABBV shares while 637 reduced holdings. 107 funds opened positions while 466 raised stakes. 994.12 million shares or 0.91% less from 1.00 billion shares in 2018Q2 were reported. Armstrong Henry H Assocs has 25,241 shares. Dodge & Cox has 0% invested in AbbVie Inc. (NYSE:ABBV) for 31,292 shares. Nj State Employees Deferred Compensation Plan holds 0.38% or 23,634 shares in its portfolio. Regent Investment Ltd Llc invested in 20,866 shares or 0.62% of the stock. Foster And Motley has 0.64% invested in AbbVie Inc. (NYSE:ABBV) for 44,970 shares. Pekin Singer Strauss Asset Mngmt Il holds 0.63% or 36,196 shares in its portfolio. 47,966 are held by Annex Advisory Lc. Twin Incorporated has 119,761 shares for 0.52% of their portfolio. Pettyjohn Wood And White invested in 15,405 shares. Bennicas Assoc invested in 15,143 shares or 1.24% of the stock. Moreover, Holderness Investments has 0.66% invested in AbbVie Inc. (NYSE:ABBV) for 15,483 shares. Cadence Natl Bank Na holds 15,299 shares or 0.55% of its portfolio. Transamerica Fincl Advisors holds 2,786 shares. Numerixs Inv Techs reported 13,450 shares. Utd Fire Grp has invested 0.12% of its portfolio in AbbVie Inc. (NYSE:ABBV).

Since August 17, 2018, it had 0 buys, and 6 sales for $26.66 million activity. SEVERINO MICHAEL also sold $4.88 million worth of AbbVie Inc. (NYSE:ABBV) on Friday, August 17. 16,850 shares valued at $1.50M were sold by GONZALEZ RICHARD A on Tuesday, December 11. CHASE WILLIAM J sold $5.40M worth of stock. Gosebruch Henry O sold $3.82 million worth of stock.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Fool.com which released: “Here’s Why AbbVie Stock Surged 21.1% in November – The Motley Fool” on December 09, 2018, also Seekingalpha.com with their article: “AbbVie teams up with Voluntis in companion digital therapeutics – Seeking Alpha” published on December 19, 2018, Seekingalpha.com published: “Biotechs lead broad market advance, XBI up 5% – Seeking Alpha” on January 04, 2019. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Seekingalpha.com and their article: “Bristol-Myers Squibb may be takeover target after Celgene bid – Credit Suisse – Seeking Alpha” published on January 08, 2019 as well as Fool.com‘s news article titled: “How Worried Should You Be About AbbVie’s $5.8 Billion Boondoggle? – Motley Fool” with publication date: December 11, 2018.

Among 26 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 3 Sell and 13 Hold. Therefore 38% are positive. Abbvie Inc had 105 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Buy” rating by Goldman Sachs on Friday, March 10. The company was maintained on Friday, October 13 by UBS. The firm has “Neutral” rating given on Monday, November 28 by Citigroup. The firm earned “Neutral” rating on Monday, September 25 by UBS. Deutsche Bank upgraded the shares of ABBV in report on Thursday, September 28 to “Hold” rating. The stock of AbbVie Inc. (NYSE:ABBV) earned “Buy” rating by Cowen & Co on Monday, November 20. The stock has “Outperform” rating by Leerink Swann on Monday, October 2. Piper Jaffray maintained AbbVie Inc. (NYSE:ABBV) on Tuesday, April 10 with “Buy” rating. Credit Suisse maintained AbbVie Inc. (NYSE:ABBV) rating on Friday, April 27. Credit Suisse has “Neutral” rating and $104 target. The rating was upgraded by Jefferies to “Buy” on Monday, December 7.

More notable recent The Gap, Inc. (NYSE:GPS) news were published by: Bizjournals.com which released: “Florida launch: SpaceX to send Lockheed-built satellite up with Harris Corp. tech – Orlando Business Journal” on December 13, 2018, also Benzinga.com with their article: “Gap, Inc. (The) (NYSE:GPS) – Today’s Pickup: Electric Vehicle Adoption Could Increase Fuel Tax Burden On Gasoline Vehicle Users – Benzinga” published on December 27, 2018, Streetinsider.com published: “Put Buying Activity in Gap, Inc. (GPS) Indicating Bearish Bias Into Earnings Announcement on Feb. 28th AMC -Susquehanna – StreetInsider.com” on January 08, 2019. More interesting news about The Gap, Inc. (NYSE:GPS) were released by: Seekingalpha.com and their article: “Wedbush likes Lululemon, Gap for the holidays – Seeking Alpha” published on December 20, 2018 as well as Fool.com‘s news article titled: “Why These 3 Retail Stocks Rallied Today – Motley Fool” with publication date: January 08, 2019.

Investors sentiment decreased to 0.97 in 2018 Q3. Its down 0.02, from 0.99 in 2018Q2. It fall, as 48 investors sold GPS shares while 134 reduced holdings. 60 funds opened positions while 116 raised stakes. 196.83 million shares or 7.38% less from 212.51 million shares in 2018Q2 were reported. Motco holds 0% or 866 shares. Bridges Inv Management accumulated 8,000 shares. Nuveen Asset Mgmt Limited Liability Corporation holds 0.07% or 476,189 shares. Sumitomo Mitsui reported 0.03% in The Gap, Inc. (NYSE:GPS). Jpmorgan Chase & Company holds 0.04% or 7.99 million shares. Mackay Shields Limited Company invested in 1.11 million shares. Sumitomo Mitsui Asset Management Limited stated it has 0.01% in The Gap, Inc. (NYSE:GPS). Beddow Capital Management reported 7,700 shares. Citadel Advsrs Ltd Liability Corporation has 0.01% invested in The Gap, Inc. (NYSE:GPS). Reilly Financial Advisors Lc, a California-based fund reported 104 shares. Glenmede Na owns 0% invested in The Gap, Inc. (NYSE:GPS) for 11,537 shares. Evergreen Mgmt Ltd Liability Corp holds 0.15% or 57,710 shares. British Columbia – Canada-based British Columbia Investment Mgmt has invested 0.02% in The Gap, Inc. (NYSE:GPS). Retirement Sys Of Alabama owns 100,066 shares or 0.01% of their US portfolio. Element Llc owns 101,438 shares.

The Gap, Inc. (NYSE:GPS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.